https://www.ndtvprofit.com/business/usfda-pulls-up-mylan-for-manufacturing-violations-at-andhra-plant?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
The U.S. FDA had issued the letter on Nov. 5, and has given the company 15 days to respond.